ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Staff Discusses New Guidelines for Core Grant Reviews, Comprehensiveness

July 24, 1992

ASCO Study Predicts Shortage of Oncologists.

March 23, 2007

Solomon Garb’s Questions/Answers

December 19, 1980

Curt, Ozols, Brown Leaving NCI; More DCT Staff Changes

June 10, 1988

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

March 25, 2011

NCI Prepares To Dispense A Torrent Of New Money For Cancer Research.

March 6, 2009